Amgen Launches First Humira (adalimumab) Biosimilar Amjevita in the US
Shots: The company has launched Amjevita (adalimumab), the first biosimilar refere...
Alpha Biopharma Reports the NMPA Acceptance of NDA for Zorifertinib to Treat EGFR-Mutated NSCLC with CNS Metastases
Shots: The NMPA has accepted the NDA for Zorifertinib to treat patients with advan...
HK inno.N Entered into an Exclusive License Agreement with mAbxience for Denosumab Biosimilar to Treat Bone Disease
Shots: HK inno.N collaborated with mAbxience for a denosumab biosimilar referencin...
Alvotech and Bioventure Receive the SFDA’s Approval of AVT02 (biosimilar, adalimumab) in Saudi Arabia
Shots: SFDA has approved AVT02, an adalimumab biosimilar referencing Humira for ma...
Celltrion Reports P-III Trial Results of CT-P16 (biosimilar, bevacizumab) for Non-Squamous Non–Small Cell Lung Cancer
Shots: The P-III trial evaluating CT-P16 vs EU-Approved Avastin (15mg/kg, q3w; &le...
Dr. Reddy’s Reports the Completion of Clinical Studies of Rituximab Biosimilar
Shots: Dr. Reddy will get ready to file in the US, EU, and other regions after the...
